| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Bhavarth P Dave, Yesha B Shah, Kunal G Maheshwari, Kaif A Mansuri, Bhadrawati S Prajapati, Humzah I Postwala, Mehul R Chorawal. Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer's Disease: Recent Trends and Future Development. Cellular and molecular neurobiology. 2023-09-19. PMID:37725199. |
alzheimer's disease (ad) is the primary cause of dementia and is characterized by the death of brain cells due to the accumulation of insoluble amyloid plaques, hyperphosphorylation of tau protein, and the formation of neurofibrillary tangles within the cells. |
2023-09-19 |
2023-10-07 |
Not clear |
| Gabrielle B Britton, Ozioma C Okonkw. A fresh look at the multi-level social determinants of disparities in Alzheimer's disease and related dementias. Alzheimer's & dementia (Amsterdam, Netherlands). vol 15. issue 3. 2023-09-18. PMID:37719283. |
a fresh look at the multi-level social determinants of disparities in alzheimer's disease and related dementias. |
2023-09-18 |
2023-10-07 |
Not clear |
| Correction to: Relationship between default mode network and resting-state electroencephalographic alpha rhythms in cognitively unimpaired seniors and patients with dementia due to Alzheimer's disease. Cerebral cortex (New York, N.Y. : 1991). 2023-09-16. PMID:37715514. |
correction to: relationship between default mode network and resting-state electroencephalographic alpha rhythms in cognitively unimpaired seniors and patients with dementia due to alzheimer's disease. |
2023-09-16 |
2023-10-07 |
Not clear |
| Alessandro Surpi, Mauro Murgia, Sonia López-Amoedo, Manuel A González-Gómez, Yolanda Piñeiro, José Rivas, Valeria Perugini, Matteo Santin, Tomás Sobrino, Pierpaolo Greco, Francisco Campos, Valentin Alek Dedi. Magnetic separation and concentration of Aβ 1-42 molecules dispersed at the threshold concentration for Alzheimer's disease diagnosis in clinically-relevant volumes of sample. Journal of nanobiotechnology. vol 21. issue 1. 2023-09-14. PMID:37710290. |
alzheimer's disease (ad) is the leading cause of dementia and loss of autonomy in the elderly, implying a progressive cognitive decline and limitation of social activities. |
2023-09-14 |
2023-10-07 |
Not clear |
| Joseph E Gaugler, Soo Borson, Fayron Epps, Regina A Shih, Lauren J Parker, Lisa C McGuir. The intersection of social determinants of health and family care of people living with Alzheimer's disease and related dementias: A public health opportunity. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2023-09-12. PMID:37698187. |
in this perspective article, we highlight current research to illustrate the intersection of social determinants of health (sdohs) and alzheimer's disease and related dementia (adrd) caregiving. |
2023-09-12 |
2023-10-07 |
Not clear |
| Ezgi Soncu Buyukiscan, Elif Yildirim, Asli Demirtas-Tatlidede, Basar Bilgic, Hakan Gurvi. An Investigation of Affective Personality Traits in Alzheimer's Disease: SEEKING as a Possible Predictor for Early-Stage Alzheimer's Dementia. Experimental aging research. 2023-09-11. PMID:37695698. |
an investigation of affective personality traits in alzheimer's disease: seeking as a possible predictor for early-stage alzheimer's dementia. |
2023-09-11 |
2023-10-07 |
Not clear |
| Ichiro Kawahata, Tomoki Sekimori, Hideki Oizumi, Atsushi Takeda, Kohji Fukunag. Using Fatty Acid-Binding Proteins as Potential Biomarkers to Discriminate between Parkinson's Disease and Dementia with Lewy Bodies: Exploration of a Novel Technique. International journal of molecular sciences. vol 24. issue 17. 2023-09-09. PMID:37686075. |
an increase in the global aging population is leading to an increase in age-related conditions such as dementia and movement disorders, including alzheimer's disease (ad), parkinson's disease (pd), and dementia with lewy bodies (dlb). |
2023-09-09 |
2023-10-07 |
Not clear |
| Nilima Khakha, Heena Khan, Amarjot Kaur, Thakur Gurjeet Sing. Therapeutic implications of phosphorylation- and dephosphorylation-dependent factors of cAMP-response element-binding protein (CREB) in neurodegeneration. Pharmacological reports : PR. 2023-09-09. PMID:37688751. |
the most common neurodegenerative disorders (ndds) include alzheimer's disease (ad), huntington's disease (hd), amyotrophic lateral sclerosis (als), parkinson's disease (pd), multiple sclerosis (ms), motor neuron disorders, psychological disorders, dementia with vascular dementia (vad), lewy body dementia (dlb), epilepsy, cerebral ischemia, mental illness, and behavioral disorders. |
2023-09-09 |
2023-10-07 |
Not clear |
| Lenora Higginbotham, E Kathleen Carter, Eric B Dammer, Rafi U Haque, Erik C B Johnson, Duc M Duong, Luming Yin, Philip L De Jager, David A Bennett, Daniel Felsky, Earvin S Tio, James J Lah, Allan I Levey, Nicholas T Seyfrie. Unbiased classification of the elderly human brain proteome resolves distinct clinical and pathophysiological subtypes of cognitive impairment. Neurobiology of disease. 2023-09-09. PMID:37689213. |
using quantitative mass spectrometry, we measured ~8000 proteins across >600 dorsolateral prefrontal cortex tissues with clinical diagnoses of no cognitive impairment (nci), mild cognitive impairment (mci), and alzheimer's disease (ad) dementia. |
2023-09-09 |
2023-10-07 |
human |
| Caglar Cosarderelioglu, Simion Kreimer, Alma I Plaza-Rodriguez, Pablo A Iglesias, C Conover Talbot, Helmy M Siragy, Robert M Carey, Ceereena Ubaida-Mohien, Brian O'Rourke, Luigi Ferrucci, David A Bennett, Jeremy Walston, Peter Abadi. Decoding Angiotensin Receptors: TOMAHAQ-Based Detection and Quantification of Angiotensin Type-1 and Type-2 Receptors. Journal of the American Heart Association. 2023-09-08. PMID:37681524. |
we have used this method to quantify angiotensin type-1 and type-2 receptors in postmortem frontal cortex samples of older adults (n=28) with alzheimer dementia. |
2023-09-08 |
2023-10-07 |
human |
| Nadine Bittner, Cleo S M Funk, Alexander Schmidt, Felix Bermpohl, Eva J Brandl, Engi E A Algharably, Reinhold Kreutz, Thomas G Rieme. Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer's Disease and Parkinson's Dementia: Systematic Review and Meta-Analysis. Drugs & aging. 2023-09-08. PMID:37682445. |
psychiatric adverse events of acetylcholinesterase inhibitors in alzheimer's disease and parkinson's dementia: systematic review and meta-analysis. |
2023-09-08 |
2023-10-07 |
Not clear |
| Felix Dörr, Simona Schäfer, Fredrik Öhman, Nicklas Linz, Timothy Hadarsson Bodin, Johan Skoog, Anna Zettergren, Silke Kern, Ingmar Skoog, Johannes Tröge. Dissociating memory and executive function impairment through temporal features in a word list verbal learning task. Neuropsychologia. 2023-09-08. PMID:37683887. |
the rey auditory verbal learning test (ravlt) is an established verbal learning test commonly used to quantify memory impairments due to alzheimer's disease (ad) both at a clinical dementia stage or prodromal stage of mild cognitive impairment (mci). |
2023-09-08 |
2023-10-07 |
human |
| Ling Xu, Noelle L Fields, Kathryn M Daniel, Daisha J Cipher, Brooke A Troutma. Reminiscence and Digital Storytelling to Improve the Social and Emotional Well-Being of Older Adults With Alzheimer's Disease and Related Dementias: Protocol for a Mixed Methods Study Design and a Randomized Controlled Trial. JMIR research protocols. vol 12. 2023-09-07. PMID:37676706. |
reminiscence and digital storytelling to improve the social and emotional well-being of older adults with alzheimer's disease and related dementias: protocol for a mixed methods study design and a randomized controlled trial. |
2023-09-07 |
2023-10-07 |
human |
| Ling Xu, Noelle L Fields, Kathryn M Daniel, Daisha J Cipher, Brooke A Troutma. Reminiscence and Digital Storytelling to Improve the Social and Emotional Well-Being of Older Adults With Alzheimer's Disease and Related Dementias: Protocol for a Mixed Methods Study Design and a Randomized Controlled Trial. JMIR research protocols. vol 12. 2023-09-07. PMID:37676706. |
increasing attention is being given to the growing concerns about social isolation, loneliness, and compromised emotional well-being experienced by young adults and older individuals affected by alzheimer disease and related dementias (adrd). |
2023-09-07 |
2023-10-07 |
human |
| Teruyuki Matsuoka, Jin Narumoto, Fukiko Morii-Kitani, Fumitoshi Niwa, Toshiki Mizuno, Mitsunari Abe, Harumasa Takano, Noritaka Wakasugi, Atsushi Shima, Nobukatsu Sawamoto, Hiroshi Ito, Wataru Toda, Takashi Hanakaw. Contribution of amyloid and putative Lewy body pathologies in neuropsychiatric symptoms. International journal of geriatric psychiatry. vol 38. issue 9. 2023-09-01. PMID:37655505. |
similarities and differences in the npss between preclinical/prodromal alzheimer's disease (ad) and prodromal parkinson's disease dementia (pdd)/dementia with lewy bodies (dlb) may exist. |
2023-09-01 |
2023-09-07 |
Not clear |
| JiWon Choi, Van Ta Park, Edward Nguyen, Andrew Jung, Janice Tso. Understanding the caregiving experiences of Asian Indian, Chinese, Korean, and Vietnamese American family care partners of persons living with dementia. Aging & mental health. 2023-09-01. PMID:37655598. |
disparities impacting dementia health care exist in racial/ethnic minority groups, including asian americans, an understudied population in alzheimer's disease and related dementias. |
2023-09-01 |
2023-09-07 |
Not clear |
| John J Alam, Paul Maruff, Susan Doctrow, Hui-May Chu, Jennifer Conway, Stephen N Gomperts, Charlotte Teunisse. Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies. Neurology. 2023-09-01. PMID:37657939. |
in a proportion of patients, dementia with lewy bodies (dlb) is associated with alzheimer's disease (ad) co-pathology, which is linked to accelerated cognitive decline and more extensive cortical atrophy. |
2023-09-01 |
2023-09-07 |
Not clear |
| Xiaoyu Tang, Zhipeng Kan, Na Li, Jinbao Huang, Jinsong Zhang, Henry J Thompson, Feng Gao, Yong Shen, Liang Zhang, Zhongwen Xie, Xiaochun Wan, Yijun Wan. Mechanisms underlying large-leaf yellow tea mediated inhibition of cognitive impairment in the 5xFAD model of Alzheimer's disease. Phytomedicine : international journal of phytotherapy and phytopharmacology. vol 120. 2023-08-31. PMID:37651754. |
alzheimer's disease (ad) is the most common cause of dementia and is characterized by amyloid-β (aβ) peptides and hyperphosphorylated tau proteins. |
2023-08-31 |
2023-09-07 |
Not clear |
| Russell P Sawyer, Bradford B Worrall, Virginia J Howard, Michael G Crowe, George Howard, Hyacinth I Hyacint. Methods of a Study to Assess the Contribution of Cerebral Small Vessel Disease and Dementia Risk Alleles to Racial Disparities in Vascular Cognitive Impairment and Dementia. Journal of the American Heart Association. 2023-08-29. PMID:37642037. |
we describe here the methods of an ancillary study to the regards (reason for geographic and and racial difference in stroke) study, which will examine the role of magnetic resonance imaging markers of cerebral small vessel disease and vascular as well as genetic risk factors for alzheimer's disease and related dementias in racial disparity in the prevalence and trajectory of vascular cognitive impairment and dementia in non-hispanic white and non-hispanic black participants. |
2023-08-29 |
2023-09-07 |
human |
| Kara Dassel, Rebecca L Utz, Ana Sanchez-Birkhead, Sara Carbajal-Salisbury, Jeannette Villalta, Moroni Cajavilca, Lauren Solkowski, Nancy Aruscavage, Kathie Supiano, Eli Iaco. Health Disparities in Advance Care Planning: Development of a Spanish-Language LEAD Guide (Life-Planning in Early Alzheimer's and Other Dementias). Health equity. vol 7. issue 1. 2023-08-28. PMID:37638115. |
health disparities in advance care planning: development of a spanish-language lead guide (life-planning in early alzheimer's and other dementias). |
2023-08-28 |
2023-09-07 |
Not clear |